Hi
@valincarter I guess that's for each investor to decide.
Personally, I don't think much is pricing in the new company at the current market cap of $11m
However, once the Alcidion transaction has been completed, with the issue of 400m shares to Alcidion and another 64m through a broker to raise a further $2m cash, the implied market cap of the new company will be $43m at today's price of 7.4c.
Usually in these types of transactions, the 400m vendor shares have to be held in escrow for 12 or 24 months - which means those shares are tied up and they can't be sold.
If you give credence to
@Lefevre 's posts (I would) re: the $2m raising, these shares are going to parties close to the company with their intentions to not sell and hold out for a take-over.
So, while the market cap will increase with the issue of the extra shares, the free-float of available shares will be so tightly held that the market cap will be the equivalent of what it is now - $11m - with just 138m shares on issue. Also, a lot of these "free-float" shares will also be tightly held by lucky investors who have been able to build up their position in the background over the past few weeks and months. They company will also have approx. $7.0m in cash.
All the above is something to consider heavily even before you look at the company itself.
Considering the above, my price target for 6-12 months is 35c+ (200m Market Cap) and if Alcidion crack even a portion of the US market, then a buy-out price of $3.50 in 24-36 months ($2bn)
